Zenas BioPharma (ZBIO) Is Up 32.5% After Securing Global Rights to Orelabrutinib in MS Deal

Retrieved on: 2025-10-10 16:34:57

Tags for this article:

Click the tags to see associated articles and topics

Zenas BioPharma (ZBIO) Is Up 32.5% After Securing Global Rights to Orelabrutinib in MS Deal. View article details on hiswai:

Excerpt

Zenas BioPharma and InnoCare Pharma recently announced a transformative license agreement, granting Zenas global development and commercialization ...

Article found on: finance.yahoo.com

View Original Article